Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaaki Inaba

Showing results (91-100 of 430) with videos related to

Pageof 43
Sort By:
Journal of Toxicologic Pathology|January 25, 2012
Enhanced Urinary Bladder, Liver and Colon Carcinogenesis in Zucker Diabetic Fatty Rats in a Multiorgan Carcinogenesis Bioassay: Evidence for Mechanisms Involving Activation of PI3K Signaling and Impairment of p53 on Urinary Bladder CarcinogenesisNaomi Ishii, Min Wei, Anna Kakehashi, et al.
Nephron. Clinical Practice|September 17, 2011
Relationship between fat mass and serum high-sensitivity C-reactive protein levels in prevalent hemodialysis patientsEiji Ishimura, Senji Okuno, Naoki Tsuboniwa, et al.
Clinical Endocrinology|January 29, 2008
Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunctionShinsuke Yamada, Masaaki Inaba, Masafumi Kurajoh, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 20, 2007
Significance of time-course changes of serum bone markers after parathyroidectomy in patients with uraemic hyperparathyroidismAiji Yajima, Masaaki Inaba, Yoshio Ogawa, et al.
Journal of the American Society of Nephrology : JASN|September 15, 2007
Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidismTakehisa Kawata, Yasuo Imanishi, Keisuke Kobayashi, et al.
Life Sciences|September 2, 2008
Association of glycated albumin, but not glycated hemoglobin, with peripheral vascular calcification in hemodialysis patients with type 2 diabetesShinsuke Yamada, Masaaki Inaba, Kaori Shidara, et al.
Obesity (Silver Spring, Md.)|August 14, 2010
Different impacts of neck circumference and visceral obesity on the severity of obstructive sleep apnea syndromeYuji Kawaguchi, Shinya Fukumoto, Masaaki Inaba, et al.
Clinical Chemistry|December 20, 2003
Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormoneMasaaki Inaba, Kiyoshi Nakatsuka, Yasuo Imanishi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 10, 2008
Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance testHarumi Nagayama, Masaaki Inaba, Reiko Okabe, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 24, 2004
Significance of Bio-intact PTH(1-84) assay in hemodialysis patientsMasaaki Inaba, Senji Okuno, Yasuo Imanishi, et al.
Pageof 43

Showing results (91-100 of 430) with videos related to

Sort By:
Pageof 43
Journal of Toxicologic Pathology|January 25, 2012
Enhanced Urinary Bladder, Liver and Colon Carcinogenesis in Zucker Diabetic Fatty Rats in a Multiorgan Carcinogenesis Bioassay: Evidence for Mechanisms Involving Activation of PI3K Signaling and Impairment of p53 on Urinary Bladder CarcinogenesisNaomi Ishii, Min Wei, Anna Kakehashi, et al.
Nephron. Clinical Practice|September 17, 2011
Relationship between fat mass and serum high-sensitivity C-reactive protein levels in prevalent hemodialysis patientsEiji Ishimura, Senji Okuno, Naoki Tsuboniwa, et al.
Clinical Endocrinology|January 29, 2008
Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunctionShinsuke Yamada, Masaaki Inaba, Masafumi Kurajoh, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 20, 2007
Significance of time-course changes of serum bone markers after parathyroidectomy in patients with uraemic hyperparathyroidismAiji Yajima, Masaaki Inaba, Yoshio Ogawa, et al.
Journal of the American Society of Nephrology : JASN|September 15, 2007
Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidismTakehisa Kawata, Yasuo Imanishi, Keisuke Kobayashi, et al.
Life Sciences|September 2, 2008
Association of glycated albumin, but not glycated hemoglobin, with peripheral vascular calcification in hemodialysis patients with type 2 diabetesShinsuke Yamada, Masaaki Inaba, Kaori Shidara, et al.
Obesity (Silver Spring, Md.)|August 14, 2010
Different impacts of neck circumference and visceral obesity on the severity of obstructive sleep apnea syndromeYuji Kawaguchi, Shinya Fukumoto, Masaaki Inaba, et al.
Clinical Chemistry|December 20, 2003
Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormoneMasaaki Inaba, Kiyoshi Nakatsuka, Yasuo Imanishi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 10, 2008
Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance testHarumi Nagayama, Masaaki Inaba, Reiko Okabe, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 24, 2004
Significance of Bio-intact PTH(1-84) assay in hemodialysis patientsMasaaki Inaba, Senji Okuno, Yasuo Imanishi, et al.
Pageof 43